“Systematic Review and Meta-Analysis of the Efficacy and Safety of Amfepramone and Mazindol As a Monotherapy for the Treatment of Obese or Overweight Patients”. Clinics 72, no. 5 (May 1, 2017): 317–324. Accessed May 4, 2024. https://revistas.usp.br/clinics/article/view/133343.